메뉴 건너뛰기
Journal of Neuropsychiatry and Clinical Neurosciences
Volumn 24, Issue 4, 2012, Pages
Long-term vagus nerve stimulation for severe refractory depression: A case study with a six-year follow-up
Author keywords

[No Author keywords available]
Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; DULOXETINE; ESZOPICLONE; ETIRACETAM; FLUOXETINE; MIRTAZAPINE; SERTRALINE; TOPIRAMATE; VENLAFAXINE; ZOLPIDEM;
EID: 84871352539     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11110342     Document Type: Letter
Times cited : (6)
References (8)
  • 1
    • 34248381347 scopus 로고    scopus 로고
    • Definition, assessment, and staging of treatmentresistant refractory major depression: A review of current concepts and methods
    • Berlim MT, Turecki G: Definition, assessment, and staging of treatmentresistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007; 52:46-54
    • (2007) Can J Psychiatry , vol.52 , pp. 46-54
    • Berlim, M.T.1    Turecki, G.2
  • 3
    • 77952330742 scopus 로고    scopus 로고
    • Two-year outcome of vagus nerve stimulation in treatment-resistant depression
    • Bajbouj M, Merkl A, Schlaepfer TE, et al: Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 2010; 30:273-281
    • (2010) J Clin Psychopharmacol , vol.30 , pp. 273-281
    • Bajbouj, M.1    Merkl, A.2    Schlaepfer, T.E.3
  • 4
    • 24044463171 scopus 로고    scopus 로고
    • A one-year comparison of vagus nerve stimulation with treatment as usual for treatmentresistant depression
    • George MS, Rush AJ, Marangell LB, et al: A one-year comparison of vagus nerve stimulation with treatment as usual for treatmentresistant depression. Biol Psychiatry 2005; 58:364-373
    • (2005) Biol Psychiatry , vol.58 , pp. 364-373
    • George, M.S.1    Rush, A.J.2    Marangell, L.B.3
  • 5
    • 26644452527 scopus 로고    scopus 로고
    • Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
    • Nahas Z, Marangell LB, Husain MM, et al: Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005; 66:1097-1104
    • (2005) J Clin Psychiatry , vol.66 , pp. 1097-1104
    • Nahas, Z.1    Marangell, L.B.2    Husain, M.M.3
  • 6
    • 24044505312 scopus 로고    scopus 로고
    • Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study
    • Rush AJ, Sackeim HA, Marangell LB, et al: Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005; 58:355-363
    • (2005) Biol Psychiatry , vol.58 , pp. 355-363
    • Rush, A.J.1    Sackeim, H.A.2    Marangell, L.B.3
  • 7
    • 79953787411 scopus 로고    scopus 로고
    • Effectiveness and safety of vagus nerve stimulation for severe treatmentresistant major depression in clinical practice after FDA approval: Outcomes at 1 year
    • Cristancho P, Cristancho MA, Baltuch GH, et al: Effectiveness and safety of vagus nerve stimulation for severe treatmentresistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry 2011; 72: 1376-1382
    • (2011) J Clin Psychiatry , vol.72 , pp. 1376-1382
    • Cristancho, P.1    Cristancho, M.A.2    Baltuch, G.H.3
  • 8
    • 0034784012 scopus 로고    scopus 로고
    • Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome
    • Sackeim HA, Rush AJ, George MS, et al: Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25:713-728
    • (2001) Neuropsychopharmacology , vol.25 , pp. 713-728
    • Sackeim, H.A.1    Rush, A.J.2    George, M.S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.